Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors

European Journal of Pharmacology

Volumn 474, Issue 2-3, 2003, Pages 195-198

  Franklin, Allyn ^a   Stella, Nephi ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cannabinoid; Inflammation; Microglial cell; Migration

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ARACHIDONYLCYCLOPROPYLAMIDE; CANNABIDIOL; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOL; PERTUSSIS TOXIN; RIMONABANT; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

EID: 0142038864     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02074-0     Document Type: Article

References (12)

1. 2+-induced relaxation in CB1 receptor-deficient mice. Hypotension. 39:2002;251-257.
2. Hillard C.J., Manna S., Greenberg M.J., Dicamelli R., Ross R., Stevenson L.A., Murphy V., Pertwee R.G., Cambell W.B. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J. Pharmacol. Exp. Ther. 289:1999;1427-1433.
3. Járai Z., Wagner J.A., Varga K., Lake K.D., Compton D.R., Martin B.R., Zimmer A.M., Bonner T.I., Buckley N.E., Mezey E., Razdan R.K., Zimmer A., Kunos G. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14136-14141.
4. Mitchison T.J., Cramer L.P. Actin-based cell motility and cell locomotion. Cell. 84:1996;371-379.
5. Offertáler L., Mo F., Bátkai S., Liu J., Begg M., Razdan R.K., Martin B.R., Bukoski R.D., Kunos G. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol. Pharmacol. 63:2003;699-705.
6. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
7. Rinaldi-Carmona M., Barth F., Millan J., Derocq J.-M., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Brelière J.-C., Le Fur G. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:1998;644-650.
8. Showalter V.M., Compton D.R., Martin B.R., Abood M.E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278:1996;989-999.
9. Song Z.-H., Zhong M. CB1 cannabinoid receptor-mediated cell migration. J. Pharmacol. Exp. Ther. 294:2000;204-209.
10. Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K., Stella N. Non-psychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23:2003;1398-1405.
11. Watanabe N., Mitchison T.J. Single-molecule speckle analysis of actine filament turnover in lamellipodia. Science. 295:2002;1083-1087.
12. Wilkinson P.C. Assays of leucocyte locomotion and chemotaxis. J. Immunol. Methods. 216:1998;139-153.